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OBJECTIVE—Obesity induces a program of systemic inﬂam-
mation that is implicated in the development of many of its
clinical sequelae. Hepatic inﬂammation is a feature of obesity-
induced liver disease, and our previous studies demonstrated
reduced hepatic steatosis in obese mice deﬁcient in the C-C
chemokine receptor 2 (CCR2) that regulates myeloid cell recruit-
ment. This suggests that a myeloid cell population is recruited to
the liver in obesity and contributes to nonalcoholic fatty liver
disease.
RESEARCH DESIGN AND METHODS—We used ﬂuores-
cence-activated cell sorting to measure hepatic leukocyte popu-
lations in genetic and diet forms of murine obesity. We
characterized in vivo models that increase and decrease an
obesity-regulated CCR2-expressing population of hepatic leuko-
cytes. Finally, using an in vitro co-culture system, we measured
the ability of these cells to modulate a hepatocyte program of
lipid metabolism.
RESULTS—We demonstrate that obesity activates hepatocyte
expression of C-C chemokine ligand 2 (CCL2/MCP-1) leading to
hepatic recruitment of CCR2
 myeloid cells that promote hepa-
tosteatosis. The quantity of these cells correlates with body mass
and in obese mice represents the second largest immune cell
population in the liver. Hepatic expression of CCL2 increases
their recruitment and in the presence of dietary fat induces
hepatosteatosis. These cells activate hepatic transcription of
genes responsible for fatty acid esteriﬁcation and steatosis.
CONCLUSIONS—Obesity induces hepatic recruitment of a
myeloid cell population that promotes hepatocyte lipid storage.
These ﬁndings demonstrate that recruitment of myeloid cells to
metabolic tissues is a common feature of obesity, not limited to
adipose tissue. Diabetes 59:916–925, 2010
O
besity induces hepatic accumulation of triglyc-
erides (TGs) and, in a large proportion of obese
individuals, leads to the development of nonal-
coholic fatty liver disease (1). Liver TG storage
in the context of obesity is achieved through a complex
program coordinated by transcriptional regulators, includ-
ing SREBP1c (2), PPAR-, (3,4), Foxo1 (5), and XBP1 (6).
Obesity also increases delivery of free fatty acids (FFAs)
to the liver from adipose tissue, which are esteriﬁed and
deposited as TG in cytoplasmic lipid droplets, and de-
creases TG export by promoting endoplasmic reticulum
stress (7).
Another cardinal feature of obesity and nonalcoholic
fatty liver disease is hepatic inﬂammation. Similar to its
effects on adipose tissue, obesity induces hepatic inﬂam-
mation, as reﬂected by increased production of proinﬂam-
matory cytokines and acute-phase reactants and by
activation of NF-B and JNK regulated pathways (8,9). In
addition, myeloid-macrophage populations are key medi-
ators of obesity-induced inﬂammation. Recent data sug-
gest a role for local immune cells in the regulation of
hepatic insulin sensitivity in response to obesity. Deletion
of Ppard within hematopoietic cells polarizes the liver
resident macrophages, Kupffer cells (KCs), toward an
M1/classically activated state and reduces systemic insulin
sensitivity in high-fat–fed mice (10,11). Despite the evi-
dence of a close relationship between hepatosteatosis and
inﬂammation, this inﬂammatory state remains poorly
characterized.
In adipose tissue, inﬂammation is caused in part by the
recruitment and activation of CCR2
 adipose tissue mac-
rophages (12,13). CCR2-deﬁcient mice have improved
whole-body insulin sensitivity and glucose homeostasis.
Consistently, mice overexpressing CCL2, the primary li-
gand of CCR2, in adipose tissue accumulate more adipose
tissue macrophages (ATMs) and are insulin resistant
(14,15). Interestingly, CCR2 deﬁciency protects mice from
nonalcoholic fatty liver disease after high-fat feeding,
implying that a CCR2-bearing cell is critical for develop-
ment of hepatosteatosis. Studies in humans have shown
that hepatic expression of CCL2 is increased in obesity
and nonalcoholic fatty liver disease (16). These observa-
tions lead us to hypothesize that obesity induces recruit-
ment of a CCR2
 myeloid cell population that promotes
hepatic steatosis.
RESEARCH DESIGN AND METHODS
Mice. C57BL/6J and B6.V-Lep/obJ mice were from The Jackson Laboratory
(Bar Harbor, ME) and housed in ventilated cages in a pathogen-free barrier
facility with a 12-h light/dark cycle. Mice had free access to autoclaved water
and irradiated pellet food. Ccr2
/ mice were described previously (17).
High-fat diet feeding, with 60% of calories from lipids (D12492; Research
Diets), began at 6 weeks of age, unless otherwise noted. Mice on a low-fat diet
(LFD) received the standard food (PicoLab Rodent 20; LabDiet). Mice were
killed by CO2 asphyxiation, and tissues were stored at 80°C. All animal
experiments were approved by the Columbia Institutional Animal Care and
Use Committee.
Expression proﬁling. Microarray experiments were performed as previously
described (18). Samples from 45 22- to 24-week-old mice were included: four
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916 DIABETES, VOL. 59, APRIL 2010 diabetes.diabetesjournals.orgfrom each of the following groups: C57BL/6J males, high-fat–fed C57BL/6J
males, calorie-restricted C57BL/6J males, calorie-restricted B6.Cg Ay/
 males,
B6.Cg Ay/
 females, B6.V Lep
ob/ob females, and exercised male B6.Cg Ay/
,a s
well as ﬁve male B6.Cg Ay/
 males. Three from each of the following groups
were included: C57BL/6J females, B6.V Lep
ob/ob females treated with pioglita-
zone, B6.Cg Ay/
 females treated with pioglitazone (Takeda NA), and B6.V
Lep
ob/ob females treated with CL316243 (Sigma-Aldrich). Data and experimen-
tal details have been deposited in the GEO database (www.ncbi.
nlm.nih.gov/geo).
Liver perfusion. Perfusion was performed as described previously with
slight modiﬁcation (19). Mice were anesthetized, and the vena cava was
catheterized using a 23-gauge catheter. The thoracic vena cava was then
clamped, and the perfusion was initiated at 5 ml/min with buffers described by
Resseguie et al. (20) supplemented with 30 mg Collagenase Type I (Worthing-
ton Biochemical) and two Complete Protease Inhibitor tablets (Roche). Livers
were disassociated in ﬂuorescence-activated cell sorting (FACS) buffer (500
ml PBS, 1 g BSA) and passed through a cell strainer.
Immunophenotyping. Liver cells were cooled on ice and counted using a
hemocytometer. They were centrifuged at 500g for 5 min at 4°C and
resuspended in FACS buffer at a concentration of 7  10
6 cells/ml. Cells were
incubated in the dark for 30 min in FcBlock (BD Pharmingen) and then for an
additional 45 min with ﬂuorophore-conjugated antibodies or isotype controls.
The antibodies used were as follows: CD11b-PE and APC, CD11c-PE and
PE-TR, CD3e-PE and FITC, and NK1.1-APC (eBioscience), B220-PE-TR
(Caltag Laboratories), CD45.1-PE and CD45.2-Percp-Cy5.5 (BD Pharmingen),
and F4/80-APC (AbD Serotec). After incubation with primary antibodies, cells
were washed twice, resuspended in FACS buffer containing 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI), and analyzed on an LSRII ﬂow cytom-
eter (Becton Dickson) equipped with four excitation lines. Data analysis was
performed using Flowjo software (Tree Star). All samples were gated on
DAPI
 cells before quantiﬁcation. Cells were sorted into Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing 20% fetal bovine serum on a BD FACS
Aria Cell Sorter.
Tissue culture. Hepatocytes were isolated from disassociated livers by three
50g centrifugations followed by centrifugation over Percoll density gradient
for 10 min at 50g. Hepatocytes were plated on Collagen I (Sigma-Aldrich)
coated 24-well plates and were washed after2hi nDMEM 10% fetal bovine
serum, 1% penicillin/streptomycin. After 2 more hours, cells were washed and
media were replaced with Hepatozyme (Invitrogen), a proprietary formulation
with a glucose concentration of 4.5 g/l, and co-cultured with recruited myeloid
cells (RMCs) for 18 h. RMCs were FACS sorted from obese mice after 20–25
weeks of high-fat feeding and cultured in macrophage medium (DMEM
containing 20% L-cell conditioned medium, 10% fetal bovine serum, 1%
penicillin/streptomycin) on cell culture inserts for 24 h before hepatocyte
co-culture.
Adenoviral preparation. Recombinant adenovirus encoding human CCL2 or
LacZ (Vector BioLabs) was ampliﬁed in HEK293 cells (ATCC) and puriﬁed
with an Adeno-X Maxi Puriﬁcation Kit (Clontech Laboratories). The 7-week-
old male mice were injected with recombinant adenovirus intravenously at a
dose of 1.1  10
6 pfu/g in a total volume of 0.1 ml. Livers were ﬁxed and
analyzed by hematoxylin and eosin staining to evaluate hepatic histology.
Serum alanine transaminase and aspartate transaminase activity were mea-
sured using commercial assays (Thermo Electron). Serum levels of human
CCL2 were measured using a commercial enzyme-linked immunosorbent
assay (ELISA) (R&D Systems).
Metabolic studies. Fasting glucose and insulin measurements were taken
after a 6-h fast. Glucose was measured with the FreeStyle blood glucose meter
(Abbott Laboratories). Insulin was measured using Ultrasensitive Mouse
Insulin ELISA (Alpco Diagnostics).
The insulin tolerance test was performed 3 weeks after infection. Mice
were fasted for 6 h before intraperitoneal injection of human regular insulin
(0.75 units/kg) (Humulin R; Eli Lilly). For biochemical analysis of insulin
signaling, mice were injected with insulin (5 units/kg) through tail vein after a
6-h fast, and livers were removed after 3 min. Homogenized proteins were
immunoblotted for total Akt and phospho-Akt (Cell Signaling Technology).
For SREBP1c Western blotting, nuclear and cytoplasmic protein fractions
were isolated from whole tissue (Active Motif) and immunoblotted using
anti-SREBP1c antibody (SC13551; Santa Cruz Biotechnology, Santa Cruz, CA).
Measurement of hepatic TG. TG content was quantiﬁed using a colorimetric
assay kit (Thermo Fisher Scientiﬁc) as previously described (3). Livers were
snap-frozen and stained with oil red O to visualize lipids.
Serum lipid determinations. Serum TG concentrations were measured
using a colorimetric assay kit (Thermo Fischer Scientiﬁc). Serum concentra-
tions of total cholesterol and FFAs were quantiﬁed using colorimetric assay
kits from Wako Chemicals.
Quantitative RT-PCR. Trizol reagent (Invitrogen) was used to extract RNA
from tissues. RNeasy mini-kits (Qiagen) were used to extract RNA from cells.
First-strand cDNA was synthesized using Superscript III reverse transcriptase
and random hexamer (Invitrogen). Quantitative PCR (Q-PCR) assays were
carried out as described previously (12). Supplemental Table 4 depicts PCR
primers used (all supplemental tables and ﬁgures can be found in an online
appendix at http://diabetes.diabetesjournals.org/cgi/content/full/db09-1403/
DC1). Data were normalized to Ppib using the C(t) method and are
presented as relative transcript levels.
Bone marrow transplantation. Bone marrow transplantation was per-
formed as previously described with slight modiﬁcation (18). Three recipient
mice received marrow from one donor mouse. Bone marrow was injected into
8-week-old lethally irradiated (two times 6 Gy, separated by 3–4 h) recipient
mice. Mice had free access to water supplemented with 10 	g/ml enroﬂoxacin
for 3 weeks. Donor mice expressed CD45.2, while recipients expressed the
antigenically distinguishable CD45.1. Engraftment was 
90% as assessed by
the ratio of CD45.2
 to CD45.1
 circulating cells.
Statistical analysis. Data are presented as mean  SD. For all comparisons,
P values were calculated using a Student’s t test (two-tailed distribution,
unequal variance). To assess associations, Pearson correlation coefﬁcients
were calculated.
RESULTS
Chemokines direct the trafﬁcking of immune cells to sites
of inﬂammation. To determine whether obesity activates a
chemokine-driven program in liver, we measured expres-
sion of chemokines and chemokine receptors in the livers
of a cohort of mice with varying degrees of adiposity. We
identiﬁed only one chemokine ligand and receptor pair
whose expression was positively correlated with body
mass in mice (supplemental Tables 1 and 2). Expression of
the chemokine receptor Ccr2 (r  0.46, P 
 0.01) and Ccl2
(r  0.40, P 
 0.01) correlated positively with body mass
(Fig. 1A). In addition, Ccr2 expression correlated with
expression of known acute-phase response genes and
inﬂammatory cytokines (supplemental Table 3), suggest-
ing that Ccr2 is part of the larger obesity-induced inﬂam-
matory program in the liver.
The recruitment of macrophages to adipose tissue and
other inﬂamed tissue is regulated by a subset of genes that
includes chemokines, chemokine receptors, adhesion mol-
ecules, myeloid markers, and inﬂammatory cytokines. We
looked for a similar expression proﬁle in the livers of
leptin-deﬁcient obese mice. We conﬁrmed the ﬁndings
from our microarrays that hepatic Ccl2 and Ccr2 expres-
sion is increased in obese mice (Fig. 1B). In addition, these
mice expressed greater amounts of adhesion molecules
(Icam1, Vcam1) required for recruitment of immune cells
to tissues, and markers expressed by macrophage and
populations (Itgam, Emr1). Expression of the potent
inﬂammatory cytokine Tnf was elevated as well. When
hepatocytes and the immune cell (CD45
) fractions were
isolated from livers of obese mice, Ccr2 expression was
detected exclusively in the immune cell population (Fig.
1C). Furthermore, hepatocyte expression of Ccl2 was
induced ninefold in hepatocytes isolated from obese com-
pared with hepatocytes from lean mice (Fig. 1D).
Despite these ﬁndings, we and others have previously
shown that KCs are not increased by obesity (8,18). To
determine whether obesity recruited non-KC immune cells
to the liver, we cataloged immune cells using FACS (Fig.
2A) and accounted for 
95% of hepatic immune cells.
Among myeloid cells, KCs express the F4/80 (Emr1)
macrophage antigen at high levels and were the largest
immune cell population. However, we found another pop-
ulation of myeloid cells (CD11b
) that expressed F4/80 at
low levels (Fig. 2B). Obesity modestly reduced the popu-
lation of KCs (CD45
/F4/80
) but lead to a doubling in the
distinct CD45
/CD11b
/F4/80
dim cells from 10.0 to 19.7%
(Fig. 2C) in C57BL/6J Lep
ob/ob. Only a small fraction of
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cells). In addition, we conﬁrmed a previous report (21)
that leptin deﬁciency reduces the number of NKT cells
(CD45
/CD3e
/NK1.1
). The increase in the CD45
/
CD11b
/F4/80
dim population did not represent a redistri-
bution of immune cells but an increase in its absolute
numbers in obese compared with lean mice (supplemental
Fig. 1).
To determine whether these changes were general fea-
tures of obesity or speciﬁc to leptin deﬁciency, we cata-
loged immune cells from high-fat diet (HFD)-fed obese
mice. As in the Lep
ob/ob model, HFD-fed C57BL/6J mice
had reduced KC numbers and increased CD45
/CD11b
/
F4/80
dim cells compared with LFD-fed control mice (Fig.
2D); therefore, these changes are common features of
obesity and not the consequence of a speciﬁc diet or
genetic alteration. We refer to the CD45
/CD11b
/F4/
80
dim cells as “recruited myeloid cells” (RMCs), and con-
sistent with our hypothesis, their number correlated with
body mass (Fig. 2E).
This population was morphologically and transcription-
ally distinct from KCs. Forward and side light scatter
proﬁles suggest that KCs are larger and more granular than
RMCs (Fig. 3A). Likewise, isolated RMCs are smaller than
resident KCs and contain less cytoplasm. Nonetheless,
both cell types share the typical mononuclear myeloid
morphology, with oval/kidney-shaped nuclei (Fig. 3B).
The transcriptional proﬁle of RMCs was consistent with
their being a monocytic-myeloid population recruited to
the liver through CCR2. As expected based on our sorting
criteria, KCs expressed high levels of Emr1 (F4/80), while
RMCs expressed higher amounts of Itgam (CD11b) (sup-
plemental Fig. 2). We hypothesized that the recruitment of
RMCs is responsible for the increase in Ccr2 expression
noted in livers of obese mice. Indeed, RMCs expressed
Ccr2 at 
100 times the level of KCs, indicating that this
population is primarily responsible for hepatic Ccr2 ex-
pression (Fig. 3C).
Among monocytic lineages of myeloid cells, CCR2 ex-
pression is associated with the classically inﬂammatory
(M1 polarized) phenotype. As expected, RMCs expressed
greater amounts of Tnf than KCs (Fig. 3D). Conversely, the
expression of the M2 markers Arg1 and Jag1 were higher
in KCs. However, not all markers of M2 polarization were
higher in KCs compared with RMCs. The expression of
Chi3l3(Ym1), a heparin binding lectin that is induced by
M2 polarization (22), was 
30 times higher in RMCs than
KCs (Fig. 3D). Although these data suggest that the
activation/polarization state of KCs and RMCs cannot
simply be described as M1 or M2, they do argue that
activation phenotypes of KCs and RMCs are distinct.
ATM accumulation in part depends on CCR2 (12). The
elevated expression of CCL2 in obese liver, and the high
level of expression of CCR2 in the RMCs, suggest that this
chemokine ligand/receptor pair may be important for
obesity-induced accumulation of RMCs. To test this pos-
sibility, bone marrow isolated from CCR2-deﬁcient
(C57BL/6J Ccr2
/) or control (C57BL/6J Ccr2
/) mice
was adoptively transferred into irradiated C57BL6/J mice
yielding CCR2-chimeric (CCR2KO/WT) and control
(CCR2WT/WT) mice (schematic Fig. 4A). After recovery
and short-term HFD feeding, there was no difference in
body mass, fasting serum insulin, or blood glucose be-
tween CCR2KO/WT or CCR2WT/WT mice (Fig. 4B). How-
ever, CCR2WT/WT recipients accumulated twice the
number of RMCs than weight-matched CCR2KO/WT mice
(10.5 vs. 5.5%, respectively, Fig. 4C). As would be expected
for a recruited and rapidly turning-over population of cells,
the percentage of donor-derived RMCs in CCR2WT/WT
and CCR2KO/WT recipients was 85% ( 6.3%) and 88% (
7.7%), respectively, 8 weeks after bone marrow transplan-
tation. In contrast, only 16% ( 22.4%) and 35.6% ( 20.6%)
of KCs were donor-derived in CCR2WT/WT and
CCR2KO/WT recipients, respectively. Bone marrow trans-
plantation signiﬁcantly reduces the susceptibility of mice
to obesity (23). However, after becoming obese (body
mass 
40 g, 8 months), CCR2KO/WT accumulated less
hepatic TG than weight-matched CCR2WT/WT mice
(132  54 vs. 204  58 mg/g, respectively, P 
 0.05; n  5)
(supplemental Fig. 4). Thus, obesity-induced accumulation
of RMCs and hepatic steatosis both in part depend on
hematopoietic CCR2.
In mice, CCR2 has four known ligands (CCL2, CCL7,
CCL8, and CCL12) that can induce chemotaxis in receptor-
bearing cells (24); however, hepatic expression of only
Ccl2 was elevated in obesity (supplemental Fig. 3). This
suggests that liver-derived CCL2 is responsible for RMC
recruitment in obesity. To test whether hepatic expression
of CCL2 was sufﬁcient to recruit RMCs to the liver, mice
were injected with a recombinant adenovirus (Ad-hCcl2)
designed to induce expression of human CCL2 (schematic,
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FIG. 1. Obesity induces a chemotactic program in the liver. A: Body
mass correlates with hepatic expression of Ccl2 and Ccr2 among mice
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a reduced afﬁnity (25). Expression of human Ccl2 was
detected in serum at 21 days and was expressed exclu-
sively in the liver (Fig. 5C and D). One week after
infection, RMCs were increased in livers of mice express-
ing human Ccl2 but not in the livers of control mice
infected with a LacZ-containing adenovirus (Fig. 5E). As
expected based on Fig. 2D, among Ad-LacZ–injected mice,
those on an HFD accumulated more RMCs than those on
an LFD (6.3  0.6 vs. 11.7  2.8%, P 
 0.05). These data
support the hypothesis that obesity-induced expression of
CCL2/MCP1 is sufﬁcient to increase recruitment of RMCs.
Genetic deﬁciency of Ccr2 in HFD-fed mice reduces
hepatic steatosis (12). To test whether CCL2-dependent
RMC recruitment was sufﬁcient to replicate obesity-
induced hepatic steatosis, we measured the effects of
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and serum lipids were not changed in mice overexpressing
hepatic hCCL2 (Fig. 5B, Fig. 6A, and supplemental Fig. 6A
and B). We found that in LFD-fed mice, increased hepatic
RMC content did not affect hepatic TG concentration (Fig.
6C and D); thus, RMCs are not sufﬁcient to induce steato-
sis. However, adenoviral-mediated expression of Ccl2 for 3
weeks in HFD-fed mice did increase hepatic TG content by
65% (P 
 0.01; Fig. 6C and D) compared with HFD-fed
controls. This occurred without evidence of liver hepato-
megaly, steatohepatitis, or elevation of serum transami-
nase concentration (Fig. 6B and supplemental Fig. 5A and
B). Thus, RMCs can induce the accumulation of hepatic
TG, but only in the presence of excess dietary lipids.
Hepatic expression of CCL2 in mice fed an HFD acti-
vated a lipogenic program that included upregulation of
genes required for fatty acid synthesis and TG esteriﬁca-
tion (Fig. 7A, supplemental Fig. 7). We observed a trend
for enhanced Srebf1 (SREBP1c) mRNA expression (P 
0.067) and nuclear localization (supplemental Fig. 8),
consistent with changes seen in expression of its targets
(Acaca, Fasn, and Gpam); however, expression of the
lipogenic transcription factor Mlxipl (ChREBP) was not
signiﬁcantly elevated nor was its direct target Lpkr (L-PK)
(P  0.18 and P  0.09, respectively). Expression of Dgat2,
which catalyzes the ﬁnal step in TG esteriﬁcation, was
increased in Ad-hCcl2 mice. Conversely, HFD-fed Ccr2
/
mice have diminished steatosis (12) and reduced expres-
sion of lipogenic and TG synthesis genes (Fig. 7B).
Obesity-induced steatosis is driven in part by hyperin-
sulinemia associated with hepatic insulin resistance (1);
insulin’s inhibition of gluconeogenesis is impaired,
whereas insulin-regulated lipogenesis remains intact, re-
sulting in increased TG production (2). These derange-
ments in insulin signaling did not appear to contribute
signiﬁcantly to RMC-induced steatosis. Insulin tolerance
tests in Ad-hCcl2 mice were not different from controls
(supplemental Fig. 6A), and differences in homeostasis
model assessment of insulin resistance (HOMA-IR) values
did not reach signiﬁcance (P  0.2 HFD Ad-LacZ vs.
Ad-hCcl2). Similarly, hepatic overexpression of hCCL2 did
not impair hepatic insulin signaling in HFD-fed mice
(supplemental Fig. 6C). These data suggest that RMC lead
to increased lipogenic gene expression and TG deposition
as a result of modulating SREBP1c-dependent and -inde-
pendent transcriptional activity, likely in a manner not
driven by alterations in insulin signaling. Dissociation of
hepatic insulin resistance and steatosis is also seen when
TG esteriﬁcation genes are overexpressed in liver. Modest
hepatic overexpression of Dgat2 or Gpam increases he-
patic steatosis in mice without increasing fasting glucose
or insulin (26,27). Conversely impaired hepatic lipid stor-
age can lead to liver damage (28). Thus, TG formation can
be adaptive and over the short term protect the liver from
the adverse effects of increased FFAs. If RMCs facilitate
TG esteriﬁcation, then infusion of FFAs would be pre-
dicted to activate a program of RMC recruitment. Indeed,
a 6-h infusion of oleate increased hepatic expression of
Ccl2 (supplemental Fig. 9).
To test whether RMCs could activate a hepatocyte
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RMCs from HFD-fed obese mice with primary hepatocytes
from lean mice for 18 h. The expression of both Dgat2 and
Gpam was induced in hepatocytes co-cultured with RMCs
(Fig. 8). In contrast, lipogenic and -oxidation programs
were unaffected by short-term co-culture with RMCs (Fig.
8). The esteriﬁcation of fatty acid into TG requires glycer-
ol-3-phosphate as a substrate, and recent evidence sug-
gests that production of glycerol-3-phosphate from
pyruvate (glyceroneogenesis) is the dominant source of
liver TG glycerol (29). Co-cultured RMCs increase hepato-
cyte expression of Pck1 (PEPCK) without modulating the
expression of G6pc (G6Pase). Whereas coordinately in-
creasing Pck1and G6pc drives gluconeogenesis in hepato-
cytes, isolated upregulation of Pepck would drive pyruvate
to glycerol rather than to glucose.
If the most proximal effect of RMCs on liver is to drive
expression of genes involved in lipid storage, one would
expect to ﬁnd these differences in LFD-fed Ad-hCcl2–
treated mice, despite there being no difference in TG per
se. In fact, expression of Gpam and Dgat2 was elevated in
standard diet–fed mice in which RMC numbers were
increased by hepatic CCL2 expression, 2 weeks after
adenoviral infection (supplemental Fig. 7).
DISCUSSION
The response of the immune system to foreign pathogens
and injury is critical for restoring tissue function after an
insult. However, recent studies suggest that the immune
system has also evolved to respond to metabolic stresses
and that immune cells have a role in maintaining metabolic
homeostasis (30). Most of these studies have focused on
populations of ATMs and their long-term maladaptive
contributions to insulin resistance and impaired glucose
homeostasis. Recent ﬁndings have implicated impairment
of M2 polarization of KCs in the development of insulin
resistance (11). Here we have identiﬁed a population of
hepatic myeloid cells, distinct from KCs, that are recruited
to the liver in proportion to body mass/adiposity in a
CCR2/CCL2-dependent fashion.
We have provided three lines of evidence demonstrating
a key role for these cells in the pathogenesis of obesity-
induced steatosis. First, CCR2 deﬁciency impairs RMC
accumulation and likewise reduces lipogenic gene expres-
sion and hepatic TG accumulation. It is difﬁcult to assess
the relative contributions of other CCR2-dependent popu-
lations, such as ATMs, to this phenotype. Other studies
have directly implicated inﬂammatory signals from adi-
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sensitivity. Nevertheless, the proximity of RMCs to hepa-
tocytes suggests that they contribute to the regulation of
hepatic TG metabolism.
Second, hepatic CCL2 expression leads to recruitment
of RMCs, induction of lipogenic genes, and, when accom-
panied by high-fat feeding, hepatic steatosis. However,
when CCL2 is overexpressed in LFD-fed mice, RMCs are
recruited (Fig. 5E) and expression levels of Gpam and
Dgat2 are elevated (supplementary Fig. 7), but this is not
associated with hepatic TG accumulation. These observa-
tions not only corroborate our primary hypothesis but
imply that the mechanism through which RMCs induce
steatosis is by elevating hepatic lipogenic gene expression.
This alone is insufﬁcient to drive lipid accumulation with-
out the availability of excess circulating metabolic sub-
strates (e.g., FFAs) to be channeled into this metabolic
pathway; consequently, RMC recruitment is insufﬁcient to
induce steatosis in LFD-fed subjects.
Lastly, co-culture experiments suggest that a primary
mechanism by which RMCs effect TG accumulation is by
activating a transcriptional program that facilitates FFA
esteriﬁcation into TG. Over the short term, this effect may
provide an adaptive mechanism to reduce local concen-
trations of the more biologically active FFAs and favor
storage of more inert TG. However, in the setting of
chronic lipid excess, this would compromise hepatocyte
metabolic function. During the preparation of this work,
an article appeared that provides parallel evidence for the
changes in hepatic myeloid cell populations (31). The
authors furthermore provide an alternative mechanism by
which hepatic myeloid cells induce liver inﬂammation,
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unclear whether this would lead to metabolic dysfunction.
Accumulation of RMCs in part depends on the chemo-
kine receptor CCR2. This suggests that this population
derives from CCR2-expressing M1 polarized circulating
monocytes. Likewise, RMCs express Tnf to a greater
degree than KCs, an alternatively activated tissue resident
macrophage population that is critical in maintaining
hepatic insulin sensitivity in obese animals (11). However,
expression of genes considered markers of M2-activated
macrophages such as Chi3l3 and Mrc was inconsistent,
with RMCs being categorized simply as M1 polarized. A
likely conclusion based on this observation is that the
activation state of the RMCs cannot be deﬁned strictly as
either M1 or M2 polarized. In the context of obesity, it is
unknown what stimuli lead to macrophage activation,
although it is certainly a complex process involving mul-
tiple metabolic signals (32) and possibly bacterial prod-
ucts (33). The complexity of this in vivo setting is unlikely
to mirror completely the in vitro deﬁned M1 and M2 states.
While RMCs are distinct from KCs, it is unclear whether
they are ontologically related. If RMCs are indeed precur-
sors to KCs, our data would imply that obesity accelerates
the turnover of KCs, and RMCs are recruited at an
accelerated rate to replenish the KC population. However,
there appears to be a reciprocal relationship between the
size of the RMC and KC populations: manipulations that
increase RMCs, i.e., obesity or hepatic CCL2 expression,
reduce the KC population. Therefore, if RMCs do serve as
precursors to KCs or a subpopulation of KCs, the relation-
ship would appear to be complex and our data would
suggest that accelerated accumulation of RMCs can drive
the efﬂux of KCs.
While we have demonstrated that RMCs contribute to
the development of obesity-induced hepatic steatosis, he-
patic TG storage is a feature of other diseases, including
alcoholic fatty liver disease and lipodystrophy. If RMCs
promote hepatocyte lipid storage more generally, RMCs
may contribute to these disorders as well. We demon-
strated that infusing oleate increases hepatic expression of
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delivery of fatty acids to the liver, suggesting that RMCs
may contribute to lipodystrophy-induced steatosis. In fact,
a recent report found that CCR2 blockade reduces hepatic
steatosis in lipodystrophic A-Zip mice (34).
RMCs also share characteristics with CCR2
 ATMs that
are recruited to adipose tissue and the monocyte popula-
tions that are increased in response to obesity. Interest-
ingly, as with ATMs, RMCs seem to increase with age
(compare controls of Fig. 2C [12-week-old C57BL/6J,
RMC  10.3%] and Fig. 2D [21-week-old C57BL/6J, RMC 
13.8%, P  0.06]), indicating that they may play a role in
age-dependent metabolic alterations. Understanding the
relationship of hepatic RMCs to other myeloid cell popu-
lations may provide insight into the mechanisms of
obesity-induced inﬂammation in other tissues and
thereby suggest novel therapeutic strategies for meta-
bolic diseases.
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